All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Quality Control for IG /TR Marker Identification and MRD Analysis

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F22%3A10444099" target="_blank" >RIV/00216208:11130/22:10444099 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064203:_____/22:10444099

  • Result on the web

    <a href="https://doi.org/10.1007/978-1-0716-2115-8_6" target="_blank" >https://doi.org/10.1007/978-1-0716-2115-8_6</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/978-1-0716-2115-8_6" target="_blank" >10.1007/978-1-0716-2115-8_6</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Quality Control for IG /TR Marker Identification and MRD Analysis

  • Original language description

    Selection of the proper target is crucial for clinically relevant monitoring of minimal residual disease (MRD) in patients with acute lymphoblastic leukemia using the quantitation of clonal-specific immunoreceptor (immunoglobulin/T cell receptor) gene rearrangements. Consequently, correct interpretation of the results of the entire analysis is of utmost importance. Here we present an overview of the quality control measures that need to be implemented into the process of marker identification, selection, and subsequent quantitation of the MRD level.

  • Czech name

  • Czech description

Classification

  • Type

    C - Chapter in a specialist book

  • CEP classification

  • OECD FORD branch

    30205 - Hematology

Result continuities

  • Project

    <a href="/en/project/NU20-03-00284" target="_blank" >NU20-03-00284: Antigen receptor rearrangement profiling in immune monitoring and treatment response prediction of malignant diseases</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Book/collection name

    Methods in Molecular Biology: Immunogenetics, Methods and Protocols

  • ISBN

    978-1-07-162114-1

  • Number of pages of the result

    9

  • Pages from-to

    91-99

  • Number of pages of the book

    607

  • Publisher name

    Humana Press

  • Place of publication

    United States

  • UT code for WoS chapter